![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 25, 22361-22369, June 21, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
From the Department of Biochemistry and Biophysics and the Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642
Received for publication, February 21, 2002, and in revised form, April 9, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Repeat sequences in various genomes undergo
expansion by poorly understood mechanisms. By using an oligonucleotide
system containing such repeats, we recapitulated the last steps in
Okazaki fragment processing, which have been implicated in sequence
expansion. A template containing either triplet or tandem repeats was
annealed to a downstream primer containing complementary repeats at its 5'-end. Overlapping upstream primers, designed to strand-displace varying numbers of repeats in the downstream primer, were annealed. Human DNA ligase I joined overlapping segments of repeats generating an
expansion product from the primer strands. Joining efficiency decreased
with repeat length. Flap endonuclease 1 (FEN1) cleaved the displaced
downstream strand and together with DNA ligase I produced non-expanded
products. However, both expanded and non-expanded products formed
irrespective of relative nuclease and ligase concentrations tested or
enzyme addition order, suggesting the pre-existence and persistence of
intermediates leading to both outcomes. FEN1 activity decreased with
the length of repeat segment displaced presumably because the flap
forms structures that inhibit cleavage. Increased
MgCl2 disfavored ligation of substrate intermediates that result in expansion products. Examination of expansion in vitro enables dissection of substrate and replication enzyme
dynamics on repeat sequences.
Sites in which mono- to pentanucleotide DNA sequences are repeated
are widespread in the chromosomes of organisms from bacteria to humans.
These microsatellite repeats range from tens to hundreds of base pairs
in length (1). Typically repeat sequences are highly polymorphic, and
the number of repeats at specific sites varies extensively. These
segments of repeats are inherently unstable and undergo sequence
expansions and deletions. Especially interesting are triplet repeat
sequences, because only 3 of the 10 possible triplet repeats (CAG, CGG,
and GAA) are prone to expansion (2). Propensity for expansion generally
increases with the size of the repeat region, and expansion can range
from addition of a few repeats to thousands (3). In addition, the rate
and size of sequence expansions vary between and within tissues of
organisms (4). Mechanisms of sequence expansion have attracted much
attention because of the involvement of triplet repeat expansion in the pathogenesis of at least 11 neurological disorders (3).
Genetic studies in yeast and E. coli suggest that one
mechanism of expansion involves slipped mispairing of template and
primer strands within the repeat region during DNA replication or
repair (5, 6). Such mispairing results in formation of a loop in one
strand of the helix. Looping of the template strand during replication
of the leading or lagging strand would lead to deletion, whereas that
in the primer strand would result in expansion. Triplet repeats have
been shown to be inherently flexible and mispair to form slipped DNA
intermediates (7, 8). Additionally, the quasi-palindromic nature of
triplet repeats results in the formation of stable hairpins, bubbles,
and other unconventional helical structures (Refs. 3 and 9 and
references therein). These structures in the repeat sequences could
serve as substrates for ligation-mediated expansions during
discontinuous synthesis of lagging strand.
Normally, bubble structures and hairpin loops in the genome are
repaired by the mismatch repair system. The role for this repair
pathway in sequence expansion is not clear. Hairpin loops containing
repeat sequences were found to be resistant to mismatch repair in
yeast, suggesting that their persistence contributes to expansion (10).
Although in yeast mismatch repair might offer some protection from
expansion (11), data from mouse models and Escherichia coli
suggest that initiation of mismatch repair can result in expansion
(12-14). Another factor influencing expansions is the orientation of
the repeat sequences relative to the origin of replication. Both CAG
and CGG repeat sequences exhibit greater instability when present on
the lagging strand template and are prone to expansion (15-17). This
links steps unique to discontinuous lagging strand synthesis with one
or more mechanisms of sequence expansion.
A model proposed by Gordenin et al. (18) suggests how
expansion might occur during Okazaki fragment processing. To join the
fragments generated during lagging strand synthesis, the RNA primer at
the 5'-end is strand-displaced by a DNA polymerase synthesizing an
upstream primer. This leads to the generation of a 5'-flap structure
that is cleaved by the flap endonuclease
(FEN1),1 following that the
nick is sealed by a DNA ligase to generate a contiguous daughter strand
(19). Such strand displacement in triplet repeat regions would result
in formation of flaps containing repeat sequences that form stable
secondary structures and are resistant to cleavage by FEN1. Persistence
of such flaps then leads to re-equilibration of the flap to form loops
and bubbles. Sealing of these structures by DNA ligase will expand the
daughter strand. This model implies that defective or inefficient
processing of flaps by FEN1 is a major pathway for expansion (20, 21). Moreover, triplet repeats appear to form structures that make them
uniquely prone to expansion (20-23).
We describe here a model that enables us to study the components of
repeat expansion, i.e. the repeat sequence and its
interaction with the replication and repair machinery in
vitro. Specifically, this system represents the last steps of
Okazaki fragment processing across a region containing repeat
sequences. The substrate has the flap structure produced at the 5'-ends
of Okazaki fragments just prior to the action of FEN1 nuclease.
Cleavage by FEN1 results in proper processing generating a nick
suitable for DNA ligase I leading to a product of correct length.
However, the 5'-flap can equilibrate with the template into a variety
of intermediate structures. Those substrates forming nicks can be
captured directly by DNA ligase and joined to expand the sequence. Use
of this system has allowed us to determine the properties of the repeat
substrate that promote expansion and to determine how these properties
might circumvent the characteristics of the replication enzymes that have evolved to replicate DNA accurately.
Materials--
Oligonucleotides were synthesized either by
Integrated DNA Technologies (Coralville, IA) or by Genosys
Biotechnologies (The Woodlands, TX). Radionucleotides
[ Expression and Purification of Human DNA Ligase I--
The
cDNA for human DNA ligase I was PCR-amplified from the vector
pTD-T7N (25) with PCR primers constructed to the 5' and 3' termini of
the gene. The resulting PCR fragment was isolated and inserted into the
TA cloning vector pCR to generate pCR-hLIGI. From this vector, the
cDNA was cloned into the T7 expression vector pET-15b (Novagen, WI)
using a two-part strategy. First, pCR-hLIGI was digested with
BamHI and EcoRI, which releases a fragment
containing the 3'-portion of the gene for DNA ligase I. The fragment
was isolated and inserted into pET-15b also digested with
BamHI and EcoRI to generate the plasmid
p15b-LIG3'. Next, the 5'-end of the cDNA for DNA ligase I was
isolated from pCR-hLIGI after digestion with NdeI and
BamHI and placed into p15b-LIG3' digested with the same
enzymes. The final expression vector, pHIS-hLIG1, contains the entire
cDNA for human DNA ligase I with an additional His8 tag
at the N terminus.
DNA ligase I was expressed from pHIS-hLIG1 in E. coli BL21.
Four 1-liter flasks of YT media (1 liter) were each inoculated with a
single positive colony from a fresh transformant and agitated overnight
at room temperature (23-25 °C). Typically, the culture reached an
absorbance of 0.1 at 595 nm. Then the bacterial cultures were
incubated at 37 °C with shaking until the
A595 was 0.6. Each culture was induced by the
addition of isopropyl-1-thio-
Modifying the human DNA ligase I with a histidine tail enabled us to
purify the enzyme using a two-column purification scheme. Human DNA
ligase I was purified from the cell lysate using
nickel-nitrilotriacetic acid chromatography. A 5-ml
nickel-nitrilotriacetic acid (Bio-Rad) column was equilibrated with
10-column volumes of buffer (50 mM NaH2PO4, pH 8.0; 300 mM NaCl; 15%
glycerol; 20 mM imidazole) and eluted with a 10-column
volume linear gradient of 300-600 mM imidazole in the same
buffer. Fractions were tested for DNA ligase I activity and analyzed by
SDS-PAGE stained with either Coomassie Blue or Silver. Active fractions
were pooled and dialyzed into Mono-Q low salt buffer (25 mM
HEPES, pH 7.6 (diluted from a 1 M stock), 50 mM
NaCl, 15% glycerol, and 0.1 mM EDTA). The dialyzed samples were loaded onto a 1-ml Mono-Q column (Amersham Biosciences)
equilibrated with the low salt buffer. DNA ligase I was eluted with a
10-column volume linear salt gradient of 50-600 mM NaCl in
the same buffer. Final DNA ligase I fractions were assayed for activity
and analyzed by SDS-PAGE stained with either Coomassie Blue or Silver.
Activity was determined by the ability of the fraction to ligate a
radiolabeled nick substrate in an ATP-dependent manner.
There was no detectable contamination from any
NAD-dependent ligase such as E. coli DNA ligase.
Active fractions were frozen in a Oligonucleotide Substrates--
Oligonucleotides were designed
to mimic the last steps of Okazaki fragment processing. Each substrate
consisted of a template strand annealed with a downstream primer at its
5'-end and an upstream primer at its 3'-end. The sequences of
oligonucleotides used are listed in
Table I. The template and
downstream primers contained either triplet or tandem repeats, having
complete complementarity. The triplet repeat substrates contained 10 CTG/CAG repeats, whereas the tandem repeat substrates contained three
10-nucleotide direct repeats. Both substrates contained approximately
the same percentage of GC content. After the template-downstream pair
was annealed, upstream primers containing varying number of repeats
were added to complete the substrate. The (CTG)1,
(CTG)3, and (CTG)10 substrates each contained
either 1, 3, or 10 CTG repeats at the 3'-ends within the upstream
primer. Similarly, substrates (TR)1, (TR)2, and
(TR)3 contained one, two, or three 10-nucleotide repeats at
the 3'-end of the upstream primer. In the final substrate, the upstream
and downstream primers contain sequences complementary to the template. These overlapping regions should result in a dynamic equilibrium between the primers. This would produce intermediates involving strand
displacement of one primer to form a flap and bubble structures involving one or both primers. "Nick" substrates that lacked either the CTG or tandem repeat were used with each set of substrates to
monitor the efficiency of ligation.
Prior to annealing, the downstream primer was radiolabeled at its
3'-end. The downstream primer (10 pmol) was annealed to template
T1 (25 pmol) generating a recessed 3'-end and then was extended with [
Substrates were generated by annealing the downstream primer, template,
and upstream primer at a molar ratio of 1:2:4, respectively. Downstream
and template primers were diluted into 50 µl of TE (10 mM
Tris-Cl, pH 8, and 1 mM EDTA) and heated to 100 °C for 5 min. The reaction was placed at 70 °C and allowed to cool slowly to
room temperature. Next, the appropriate upstream primer was added and
the reaction incubated at 37 °C for 30-60 min.
Enzyme Assays--
Assays contained the indicated amounts of
substrate, DNA ligase I, and/or FEN1 in reaction buffer in a final
volume of 20 µl. Reaction buffer contained 30 mM HEPES,
pH 8.0 (diluted from a 1 M stock), 40 mM KCl, 4 mM MgCl2, 0.5 mM ATP, 0.01%
Nonidet P-40, 0.5% inositol, 0.1 mg/ml bovine serum albumin, and 1 mM dithiothreitol. Assays were assembled on ice and then
incubated at 37 °C for 15 min. The reactions were stopped by the
addition of 10 µl of termination dye (95% formamide (v)/v, 1 mM EDTA with 0.5% bromphenol blue and xylene cyanol) and
heated at 95 °C for 5 min. Products were separated on an 8%
polyacrylamide, 7 M urea denaturing gel and detected by
PhosphorImager (Molecular Dynamics). Quantitation was done using
ImageQuant version 1.2 software from Molecular Dynamics. All assays
were performed at least in triplicate.
We describe here an in vitro system designed to model
mechanisms of sequence expansion during mammalian lagging strand DNA synthesis. We have used this system to explore the roles of DNA substrate structure and two enzymes central to Okazaki fragment processing, namely FEN1 and DNA ligase I.
Substrates Used to Study Sequence Expansion--
An important
feature of the system is that oligonucleotide primers are annealed in
an overlapping configuration to simulate the displacement of the 5'-end
of an Okazaki fragment by synthesis extending an upstream fragment.
Addition of FEN1 and DNA ligase I reconstitutes removal of the overlap
and joining of the fragments.
Fig. 1 gives a schematic view of the
substrates used in this study. A template strand (T)
containing either 10 CAG repeats or three 10-bp tandem repeat sequences
flanked by unique sequences was annealed with a downstream primer
(D). The downstream primer annealed with full
complementarity up to the 5'-end of the template. The downstream primer
was just long enough to be complementary to all of the repeat sequences
in the template. An upstream primer (U), also fully
complementary to the 3'-end to the template, was then annealed. For
some substrates the upstream primer extended from the 3'-end of the
template up to the downstream primer to form a nick. This upstream
primer had no repeat sequences. For other substrates the upstream
primer was extended with one triplet repeat sequence
[(CTG)1]. Such a primer would be fully
complementary to the 3'-end of the template but would overlap three
nucleotides with the downstream primer. Similarly, other substrates had
upstream primers extended with 3 [(CTG)3] or 10 triplet
repeats [(CTG)10]. A similar set of primers containing
three tandem repeats of 10 nucleotides was also constructed. For the
tandem repeat substrates we overlapped one, two, or three tandem repeat
units on the upstream and downstream primers to generate the
(TR)1, (TR)2, and (TR)3 substrates.
Overlap of the upstream and downstream primer will result in partial
strand displacement of the downstream primer off the template producing
a 5'-flap structure similar to that proposed to form during initiator
RNA removal and joining of Okazaki fragments (19). However, as the
substrates contain repeat sequences, the upstream and downstream
primers can also form alternate structures by slippage and mis-pairing,
equilibrating between these structures as represented in Fig. 1. In
this manner, the oligonucleotide system we describe here is dynamic,
recreating the structures that can form when repeat sequences overlap
in vivo. Formation of bubble intermediates with juxtaposed
5'- and 3'-ends produces a substrate, which if ligated would expand the
region of repeat sequences. However, intermediates with 5'-flaps can
serve as substrates for FEN1. Complete processing by FEN1 prior to
ligation will result in maintenance in the number of repeats spanning
the region.
Repeat Expansion by DNA Ligase--
We first determined whether
DNA ligase I can mediate repeat expansion. Varying amounts of DNA
ligase I were incubated with substrates having overlapping primers
containing repeated sequences. Downstream primers were radiolabeled at
their 3'-ends to facilitate detection and size determination of
ligation products by electrophoresis (Fig.
2, A and B).
Remarkably, the (CTG)1, (CTG)3,
(TR)1, and (TR)2 substrates with 1 and 3 units
of CTG overlaps and up to 2 units of overlapping 10-bp tandem repeat
segments, respectively, were readily joined to generate expansion
products incorporating the length of the upstream overlap (Fig. 2,
A and B, lanes 6-8 and
10-12). This indicates that sequences containing repeats
indeed equilibrate into bubble intermediates that are accessible for joining and expansion by DNA ligase I. However, longer overlaps of 30 bp in (CTG)10 and (TR)3 substrates either
failed to ligate or formed expanded sequences at very low levels
(lanes 14-16). This decrease could derive from a drop in
the proportion of expansion substrate intermediates accessible to DNA
ligase I formed in the substrate population. The potential flap and
bubble intermediate structures that can form with increasing length of
overlap rises enormously. However, it is conceivable that with
increasing length of the overlap either the bubble intermediates formed
are unstable or have a bulky structure that can interfere with the
activity of DNA ligase I. Another possible reason for the lack of
expansion of long triplet and tandem repeat overlaps is the formation
of cruciform intermediates in which the overlapping repeat sequences in
the two primers interact to form a branching helix. This intermediate also would be inaccessible to DNA ligase I.
FEN1 Cleavage of Repeat Substrates--
Strand displacement of the
downstream primer by the upstream primer should result in the
generation of a 5'-flap that is the substrate for endonucleolytic
cleavage by FEN1 (26). We tested the ability of this enzyme to cleave
repeat sequence overlaps over time. FEN1 cleaved (CTG)1,
(CTG)3, and (TR)1 substrates very rapidly. More
than 80% of these substrates was cleaved in 3 min at the employed
level of FEN1 (Fig. 3, A and
B) suggesting that smaller repeat overlaps formed flaps
readily. However, with (CTG)10, (TR)2, and
(TR)3 substrates only 40% of the total substrate was cleaved. Results published previously (27) show that increasing the
flap length with random sequences does not affect the activity of FEN1.
However, fold backs and secondary structures in the flap inhibit
cleavage (24, 28). Therefore, FEN1 was likely inhibited because repeat
sequences with increased length interacted inter- and intramolecularly
to form secondary structures that were refractory to FEN1 cleavage.
Inhibition of Expansion by FEN1--
FEN1 has been implicated in
repeat sequence expansion as yeast rad27
As with the experiment containing DNA ligase I alone, there was no
formation of maximum length expansion products from the (CTG)10 and (TR)3 substrates (Fig. 4,
A and B, lanes 25-28), although they
readily formed products that result from proper processing of the
overlapping flaps. However, the amount of substrate reacted was
significantly lower than with the smaller substrates. This is
consistent with an inhibition of FEN1 activity by structures that the
longer flaps can form. Curiously, a small proportion of
(CTG)10, (TR)2, and (TR)3
substrates formed products of intermediate expansion lengths (72-90 nt
for the (CTG)10 substrate and 79 and 89 nt for the
(TR)2 and (TR)3 substrates) in the presence of
FEN1 and DNA ligase I. These products correspond to the processing of
an intermediate in which the substrate forms both a bubble and a short
flap. Cleavage of the short flap and ligation then would yield an
expansion product but not one of the maximum possible expansion length.
The sizes of these intermediate expansion products vary in units of 3 nucleotides for the CTG repeat and in 10 nucleotides for the tandem
repeat substrate suggesting the structure of the intermediates from
which they were derived. These structures would possess bubbles on
either upstream or downstream primers having a segment of the
downstream primer with an integer repeat unit length in a flap that
would be accessible to cleavage by FEN1. This demonstrates the ability
of overlapping segments of DNA containing repeat sequence to
equilibrate into intermediate structures that can then be processed to
give rise to numerous incorrectly sized products.
Kinetics of Flap Cleavage and Ligation--
Reaction rates for
direct ligation, cleavage, and ligation of cleaved substrate were
compared in a reaction containing similar molar concentrations of FEN1
and DNA ligase I, or excess FEN1 over DNA ligase I, and the
(CTG)3 substrate (Fig. 5,
A and B). Comparing the initial rate of direct
ligation to the initial rate of cleavage at 5 fmol of FEN1 and 4 fmol
of DNA ligase I, it is evident that the ligase is more efficient than
the nuclease at 1.25 molar ratio of FEN1 to DNA ligase I (Fig.
5A). This is evident from the ligation of cleaved product,
which occurs at about the same rate as FEN1-directed cleavage,
demonstrating that cleavage limits the rate of the overall reaction.
Over the time course, however, the extent of both cleavage and ligation
of the cleaved substrate surpasses the quantity of ligation in the
reaction with ligase alone. This result suggests that the action of the
nuclease generates a substrate that is favored by the ligase.
In reactions containing 30 fmol of FEN1 and 8.5 fmol of DNA ligase,
expansion by direct ligation was inhibited. (Fig. 5B). Excess FEN1 greatly promotes the pathway of cleavage followed by
ligation. Rapid cleavage of the substrate by FEN1, when in 3.5-fold
molar excess, results in generation of the nicked intermediate that is
the favored substrate for DNA ligase. This will result in a competition
between the two pools of intermediates suitable for ligation. Because
the formation of correctly sized product is relatively rapid, it
suggests that the nicked substrate is favored over the expansion
intermediates. This is the likely mechanism resulting in decreased
expansion. In fact this observation is consistent with the behavior of
the rad27-p mutant which contains a FEN1 incapable of
binding proliferating cell nuclear antigen. The absence of
proliferating cell nuclear antigen stimulation is presumed to be
equivalent to a lower level of FEN1. The only genetic effect is an
increase in genome instability represented by increased CAN1
duplications (30). Overall these results show that the relative amounts
of expansion and maintenance are dependent on the relative levels of
FEN1 and DNA ligase in the reaction.
Persistence of Expansion and Cleavage Intermediates--
Formation
of expansion products even at high concentrations of FEN1 suggested
that the intermediates that lead to expansion by ligation are stable.
During the time of the reaction they do not equilibrate rapidly to flap
intermediates. To corroborate this conclusion we performed an order of
addition experiment. Repeat substrates were preincubated with either
DNA ligase or FEN1 for 5 min at 37 °C. This was followed by the
addition of the second enzyme and incubation at 37 °C for 10 min.
Preincubation of the substrates with DNA ligase I resulted in expansion
with the (CTG)1, (CTG)3, (TR)1, and
(TR)2 substrates (Fig. 6,
A and B, lanes 15-16 and
28-29). Addition of FEN1 to this reaction resulted in the
subsequent formation of non-expanded products (Fig. 6, A and
B, lanes 17-19 and 30-32). As was
observed before, (CTG)10 and (TR)3 substrates
did not generate expansions when preincubated with DNA ligase I (Fig.
6, A and B, lanes 41-42); however,
addition of FEN1 still resulted in formation of non-expanded products
(Fig. 6, A and B, lanes 43-45).
Preincubation of the substrates with FEN1 resulted in the cleavage of
the flaps at an efficiency comparable with the cleavage occurring over
the reaction period with all substrates (Fig. 6, A and
B, lanes 20-23, 33-36, and
46-49). Addition of DNA ligase I to the reaction resulted
in the ligation of the nicked product generated by the cleavage of the
substrates by FEN1 as well as generation of expansion products (Fig. 6,
A and B, lanes 24-26 and
37-39). With the (CTG)10 and the
(TR)3 substrates, smaller expansion products that result
from cleavage of the bubble flap intermediate by FEN1 were observed
when these substrates were preincubated with FEN1.
Importantly, significant amounts of both expanded and non-expanded
products were formed, irrespective of the order of addition of enzymes
and the preincubation. In fact, even intermediate expansion products
that were observed earlier with the longer overlaps were formed. This
suggests that both cleavage and expansion intermediates are preformed;
moreover, they are stable and persistent in solution over time.
Although overlapping repeat sequences must be in a dynamic equilibrium,
they do not equilibrate rapidly upon enzymatic removal of a portion of
the intermediates representing a particular class of structures.
Curiously, in this and other experiments we observed incomplete
utilization of the substrate even in the presence of excess enzyme.
This may be the result of denaturation of annealed substrates or may
indicate the presence of secondary structures in the substrates that
are inaccessible to both FEN1 and DNA ligase I.
Effect of Increasing MgCl2 Concentration on Generation
of Expansion Products--
All results so far indicate that the bubble
or loop intermediates that lead to expansion in repeat sequences are
relatively stable in solution. Increasing salt concentration leads to
higher stability in the backbone of double-stranded DNA and decreases breathing at the termini of DNA (31). Would increasing double helix
stability and eliminating bubble intermediates that have flexible
helical structures result in an overall decrease in expansion? To test
this concept we increased the amount of Mg2+ in the
reaction over a range of 1-10 mM. In the presence of 2 fmol of DNA ligase I, increasing MgCl2 concentration
resulted in 35% decrease in ligation efficiency of the nick substrate
(Fig. 7), demonstrating that the ligase
is slightly more active at the lower MgCl2 concentration.
However, with (CTG)1 and (CTG)3 substrates there was a 77 and 62% decrease in ligation, respectively. The decrease in the ligation efficiency for tandem repeat substrates was
comparable with the decrease in nick ligation activity (data not
shown). This suggests that in addition to altering ligation activity,
MgCl2 results in a limited alteration in structures formed
by repeat sequence overlaps which decreases the formation of expansion
products. Expansion products were detected even at the highest
concentration of divalent cation used in the reaction. This indicates
that increasing MgCl2 concentrations resulted in decreased
breathing in the substrate and reduced the overall rate of
equilibration of the substrate into its various intermediate structures
but did not eliminate bubble intermediates that lead to expansion.
Interestingly, the formation of non-expanded product in the presence of
both FEN1 and DNA ligase I by the (CTG)10, (TR)2, and (TR)3 substrates also decreased with
increasing MgCl2 (data not shown). Possibly stabilization
of the intermediates that are inaccessible to both FEN1 and DNA ligase
I occurs at higher salt concentrations. Although increasing salt
concentration alone cannot eliminate sequence expansion, such factors
that can lead to proper base pairing in repeat sequences and result in formation of stable flap intermediates should result in an overall decrease in expansion rates.
We describe here a model system to study repeat sequences and
their interaction with DNA replication and repair machinery in
vitro. The model uses oligonucleotides to mimic the last steps of
eukaryotic lagging strand synthesis, which has been implicated in the
expansion of sequences containing repeats. Consistent with the proposed
models, we report evidence that repeat sequences in vitro
form bubble and loop intermediates that are created by a slip and
mispair process (8). These intermediates were readily joined by DNA
ligase alone to give rise to an expanded daughter strand. This suggests
that presence of the appropriate sequence and of DNA ligase are the
minimum features necessary for expansion during lagging strand DNA
replication. Addition of increasing amounts of FEN1 to reactions
containing DNA ligase resulted in decreased expansion. This is
consistent with the observation that the rad27 The inhibition of FEN1 cleavage by long repeats in the displaced
strands is consistent with previous results (24, 28, 33). However,
these studies employed fixed substrates containing repeat sequences in
the region forming the 5'-flap alone. In vivo synthesis will
result in the formation of flaps displaced by the growing 3'-strand,
which then have the potential to re-equilibrate with the template. Our
model system uses equilibrating upstream and downstream primers to
represent more accurately the possible conformations that can be
assumed by repeat sequences during Okazaki fragment processing.
We found that longer flaps containing repeat sequences are not
processed efficiently by FEN1. However, these intermediates do not seem
to be substrates for DNA ligase-based expansion either, as the
(CTG)10 and (TR)3 substrates are not
efficiently joined by DNA ligase I in our hands. This suggests that
longer flaps are difficult to resolve in the normal pathway for Okazaki
fragment processing. Instead they may become substrates for
recombination repair in vivo, as single-stranded DNA has to
be resolved to complete DNA replication. Possibly large
intergenerational changes in repeat tracts that are observed in
neurological disease arises from a combination of FEN1 inhibition and
resulting recombination. Recombination also is thought to be a source
for repeat instability as triplet repeat sites have been shown to be
sites for double-strand breaks that are repaired by recombination
(34-36).
The model also is informative concerning the physical behavior of
repeat sequences under approximately physiological conditions. Results
from the order of addition experiments suggest that overlapping repeat
sequences form flap and bubble/loop intermediates that are relatively
stable and are not readily shifted to other structures. This is
significant as it suggests that once hairpin and bubble intermediates
within repeat sequences are formed in vivo, they will not
readily equilibrate to the correct base pairing and are long lived
compared with the rate of Okazaki fragment processing. These structures
may in fact be causative for large expansions in vivo as
results show that initiation of mismatch repair in mice is necessary
for sequence expansion (13, 37).
In vivo expansion occurs in sequences with large numbers of
repeats, whereas sequences of the size that we are testing essentially do not expand (38). Additionally, even at the highest levels of FEN1
used in our assay there is detectable expansion by ligation. These
results suggest that our system is lacking activities that inhibit
sequence expansion in vivo. Indeed genetic screens in yeast
implicate other replication enzymes in sequence expansion (29). A
systematic analysis of interaction and activities of various
replication proteins with these repeat substrates is required to
identify inhibitory activities that maintain the stability of small
repeat sequences. Among the proteins that could influence sequence
expansion is the DNA2-encoded nuclease/helicase. It is an
essential protein in S. cerevisiae involved in Okazaki
fragment processing (39). It has been proposed that Dna2p cleaves the RNA-containing 5'-flap on the displaced strand, leaving a shorter flap
behind that is a substrate for FEN1 cleavage (40). It also is
hypothesized that the helicase activity Dna2p is involved in removing
any secondary structure in the flap (40). However, genetic studies in
yeast do not show a role for DNA2 in sequence expansion
(29).
Longer repeats can generate a multitude of structures. Although the
tandem repeat substrates were designed not to have any internal
interactions, FEN1 cleavage was inhibited in the two tandem unit
overlap substrate, suggesting some type of folding. Clearly, additional
substrates will have to be employed to fully explore this phenomenon.
The tandem repeat substrates are likely to be valuable in future
studies of expansion mechanisms because the number of possible
conformations assumed by these substrates is small and easily analyzed.
Repeat sequence expansions are clearly influenced by the ability of the
substrates to form structures such as hairpins, bubbles, and
non-Watson-Crick pairing, which can interfere with the replication machinery (41, 42). So far only 3 of the 10 possible triplet repeats
have been shown to undergo expansion in humans (18). One of the
questions that can be addressed using this model is the ability of
other repeat sequences to undergo sequence expansion. Furthermore, as
sequence expansion also is affected in trans by the
replication and repair machinery as in the case of rad27
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]dCTP (3000-6000 Ci/mmol) were obtained form
PerkinElmer Life Sciences. T4 polynucleotide kinase and Klenow fragment
of E. coli DNA polymerase I (labeling grade) were from Roche
Diagnostics. Recombinant human FEN1 cloned into the pET-FCH expression
vector was expressed and purified from E. coli as reported
previously (24). All other reagents were the best available commercial grade.
-D-galactopyranoside to 4 mM, and growth continued for an additional 3 h. The
cells were pelleted by centrifugation, lysed by sonication, and
resuspended in lysis buffer (1 mg/ml lysozyme; 50 mM
NaH2PO4, pH 8.0; 300 mM NaCl; 15%
glycerol; 10 mM imidazole; 1% Nonidet P-40). A protease inhibitor mixture tablet from Roche Molecular Biochemicals (1 tablet
per 10 ml of lysis buffer) and phenylmethylsulfonyl fluoride (1 mM final concentration) were added to the lysis buffer to
reduce protein degradation. The resulting lysate was cleared of
cellular debris by centrifugation.
80 °C freezer until use. The
final fraction of peak activity contained 3.8 mg of total protein (0.9 mg/liter of induced culture) at greater than 85% purity. We found the
His-tagged enzyme to have properties indistinguishable from the
unmodified enzyme (data not shown).
Oligonucleotide sequences
-32P]dCTP using Klenow polymerase at
37 °C for 3 h. Unincorporated radionucleotides were removed
using Micro Bio-spin 30 chromatography columns (Bio-Rad). The labeled
downstream primer was isolated and purified on a 10% 7 M
urea-denaturing polyacrylamide gel.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (22K):
[in a new window]
Fig. 1.
Sequence expansion model.

View larger version (50K):
[in a new window]
Fig. 2.
Sequence expansion is detected on model
substrates with the addition of human DNA ligase I. Model
expansion substrates (5 fmol) containing upstream primers of increasing
length were incubated with decreasing amounts of DNA ligase I
(Lig I) (80, 8, or 2 fmol). Assays were incubated at
37 °C for 15 min as described under "Experimental Procedures."
Control lanes (S) contain only substrate. Length of the
substrate and products is given in nucleotides and noted by
arrows. A schematic diagram of each substrate is depicted
above the figure. A, substrates consisted of
template and downstream primers with 10 CTG repeats annealed to
upstream primers containing either no CTG (Nick, lanes
1-4), 1, 3, or 10 CTG repeats ((CTG)1,
lanes 5-8; (CTG)3, lanes
9-12; and (CTG)1, lanes 13-16,
respectively). B, substrates with three 10-nt tandem repeat
sequences were annealed to upstream primers containing either no tandem
repeat (NickT, lanes 1-4) or 1-3 tandem
repeats ((TR)1, lanes 5-8;
(TR)2, lanes 9-12;
(TR)3, lanes 13-16).

View larger version (16K):
[in a new window]
Fig. 3.
Increasing the number of CTG or tandem
repeats reduces FEN1 cleavage. Rate and level of FEN1 cleavage
were examined for the CTG triplet repeat. Model expansion substrates
(45 fmol), as described in Fig. 1, were incubated with FEN1 (9 fmol) in
a total reaction volume of 180 µl and incubated at 37 °C. Aliquots
(20 µl) were removed at the indicated time and stopped by the
addition of termination dye (10 µl). The cleavage products were
separated and quantified using a Molecular Dynamics PhosphorImager.
Products were quantitated and plotted as percent cleavage
versus time. Data for CTG repeats (A) and tandem
repeats (B) are shown.
strains
exhibited increased expansion of triplet repeat tracts (22, 23, 29). We
therefore tested the ability of FEN1 to inhibit sequence expansion on
repeat substrates in vitro. FEN1 was added to reactions
containing the various repeat substrates and DNA ligase I. With
increasing amounts of FEN1, expansion by direct joining of upstream and
downstream primers decreased (Fig. 4,
A and B, lanes 11-14 and
18-21). Furthermore, there was an increase in the product
expected from cleavage of the longest flap formed by strand
displacement of the overlapping repeats, followed by sealing of the
resultant nick by DNA ligase I (63 nt for CTG and 69 nt for tandem
repeat substrate). This complete processing of the substrate by FEN1
followed by ligation results in maintenance within the joined primers
of the repeat length present in the template. Remarkably, formation of
expansion products persists even at the highest levels of FEN1 used in
this assay. This suggests that some bubble intermediates formed by the
repeat substrates were stable and inaccessible to FEN1. This also
suggests that the presence of FEN1 is unable to drive the equilibration of the repeat substrate fully into the flap intermediate.

View larger version (37K):
[in a new window]
Fig. 4.
Presence of FEN1 reduces sequence
expansion. The ability of FEN1 to prevent sequence expansion was
examined by addition of FEN1 and DNA ligase I (Lig I) to the
substrates. Increasing amounts of FEN1 (0, 1, 5, 10, and 30 fmol) were
added to reactions containing DNA ligase I (8 fmol) and expansion
substrates (5 fmol) and incubated at 37 °C for 15 min as described
under "Experimental Procedures." Control lanes (S)
contain only substrate. Length of the substrate and products is given
in nucleotides and noted by arrows. Assays contain model
substrates with CTG repeats (A) or 10-nt tandem repeats
(B). Substrates are as described in Fig 1. Lanes
2, 9, 16, and 23 contain only
FEN1 (30 fmol).

View larger version (16K):
[in a new window]
Fig. 5.
Kinetics of flap cleavage and ligation.
The fate of model CTG expansion substrates in the presence of both FEN1
and DNA ligase I (Lig-I) was assessed over time with varying
ratios of FEN1/DNA ligase I. Expansion represents the fraction of
substrate that is directly ligated without any cleavage. The fraction
of substrate % corrected represents the fraction of substrate that has
been ligated following FEN1 cleavage. % cleavage represents the
total amount of substrate that is cleaved by FEN1.

View larger version (75K):
[in a new window]
Fig. 6.
Repeat substrates equilibrate into expansion
or flap intermediates. The order of addition of FEN1 and DNA
ligase I (Lig I) was varied to determine whether substrates
formed expandable intermediates that were resistant to FEN1 cleavage.
Assays contain model substrates with CTG repeats (A) or
10-nt tandem repeats (B). Substrates are as described in
Fig. 1. Substrate (5 fmol) was incubated with either DNA ligase I or
FEN1 (1, 10, or 30 fmol) for 5 min at 37 °C as described under
"Experimental Procedures." Then the second enzyme was added, and
reactions were incubated for an additional 15 min at 37 °C. Controls
included incubation of substrate with only DNA ligase I for 20 (lanes 2, 15, 28, and 41)
or 5 min (lanes 3, 16, 29, and
42) and only FEN1 (30 fmol) for 20 min (lanes 7,
20, 33, and 46). Lanes 1, 14, 27, and 40 contain only substrate (S).
Length of the substrate and products is given in nucleotides and noted
by arrows.

View larger version (18K):
[in a new window]
Fig. 7.
Disruption of secondary structure leads to
decreased expansion. By adding increasing amounts of
MgCl2 to the reactions, secondary structure in the
substrate was disrupted. Assays contain model substrates with CTG
repeats as described in Fig. 1. Substrate (5 fmol) was incubated with
DNA ligase I (2 fmol) in reactions containing 0, 1, 2, 4, 8, and 10 mM MgCl2 at 37 °C for 15 min as described
under "Experimental Procedures." The effect of MgCl2 on
ligation of nicked and triplex substrates was quantitated, and the
activity was normalized to % ligation of substrate at 0.5 mM MgCl2. Data are expressed as the relative
change in ligation of substrate versus the concentration of
MgCl2.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
mutant in
Saccharomyces cerevisiae displays a high rate of repeat
tract expansion (20, 21, 23, 32).
mutants in yeast, this model system can be used to study the
interaction of proteins with repeat sequences. Consequently, the value
of the system employed here is that it can be used to evaluate both cis and trans influences on sequence expansion.
| |
ACKNOWLEDGEMENTS |
|---|
We thank the members of the Bambara laboratory for useful discussions. We thank S. Aoyagi for valuable assistance in purification of recombinant DNA ligase I. We also thank Dr. D. Gordenin for critical review and comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant GM24441 (to R. A. B.), in part by National Institutes of Health Grant GM52426 (to J. J. Hayes), and by American Cancer Society Grant RPG-00-080-01-GMC (to D. R. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
§ Present address: University of Rochester Medical Center, Center for Aging and Developmental Biology, 601 Elmwood Ave., Box 645, Rochester, NY 14642.
¶ Present address: Integrated Nano-Technologies, LLC, P. O. Box 23447, Rochester, NY 14692.
To whom correspondence should be addressed: Dept. of
Biochemistry and Biophysics, University of Rochester Medical Center, 601 Elmwood Ave., Box 712, Rochester, NY 14642. Tel.: 585-275-3269; Fax: 585-271-2683; E-mail: robert_bambara@urmc.rochester.edu.
Published, JBC Papers in Press, April 10, 2002, DOI 10.1074/jbc.M201765200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: FEN1, flap endonuclease 1; nt, nucleotide; TR, tandem repeat.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bennett, P.
(2000)
Mol. Pathol.
53,
177-183 |
| 2. |
Sutherland, G. R.,
and Richards, R. I.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
3636-3641 |
| 3. | Usdin, K., and Grabczyk, E. (2000) Cell. Mol. Life Sci. 57, 914-931[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Fortune, M. T.,
Vassilopoulos, C.,
Coolbaugh, M. I.,
Siciliano, M. J.,
and Monckton, D. G.
(2000)
Hum. Mol. Genet.
9,
439-445 |
| 5. |
Ohshima, K.,
and Wells, R. D.
(1997)
J. Biol. Chem.
272,
16798-16806 |
| 6. |
Rolfsmeier, M. L.,
and Lahue, R. S.
(2000)
Mol. Cell. Biol.
20,
173-180 |
| 7. | Chastain, P. D., and Sinden, R. R. (1998) J. Mol. Biol. 275, 405-411[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Pearson, C. E.,
Wang, Y. H.,
Griffith, J. D.,
and Sinden, R. R.
(1998)
Nucleic Acids Res.
26,
816-823 |
| 9. |
Petruska, J.,
Arnheim, N.,
and Goodman, M. F.
(1996)
Nucleic Acids Res.
24,
1992-1998 |
| 10. |
Moore, H.,
Greenwell, P. W.,
Liu, C. P.,
Arnheim, N.,
and Petes, T. D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1504-1509 |
| 11. | Rolfsmeier, M. L., Dixon, M. J., and Lahue, R. S. (2000) Mol. Cell 6, 1501-1507[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Jaworski, A.,
Rosche, W. A.,
Gellibolian, R.,
Kang, S.,
Shimizu, M.,
Bowater, R. P.,
Sinden, R. R.,
and Wells, R. D.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11019-11023 |
| 13. | Manley, K., Shirley, T. L., Flaherty, L., and Messer, A. (1999) Nat. Genet. 23, 471-473[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Kovtun, I. V.,
Therneau, T. M.,
and McMurray, C. T.
(2000)
Hum. Mol. Genet.
9,
2767-2775 |
| 15. | Freudenreich, C. H., Stavenhagen, J. B., and Zakian, V. A. (1997) Mol. Cell. Biol. 17, 2090-2098[Abstract] |
| 16. |
Miret, J. J.,
Pessoa-Brandao, L.,
and Lahue, R. S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12438-12443 |
| 17. |
Balakumaran, B. S.,
Freudenreich, C. H.,
and Zakian, V. A.
(2000)
Hum. Mol. Genet.
9,
93-100 |
| 18. | Gordenin, D. A., Kunkel, T. A., and Resnick, M. A. (1997) Nat. Genet. 16, 116-118[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Bambara, R. A.,
Murante, R. S.,
and Henricksen, L. A.
(1997)
J. Biol. Chem.
272,
4647-4650 |
| 20. |
Kokoska, R. J.,
Stefanovic, L.,
Tran, H. T.,
Resnick, M. A.,
Gordenin, D. A.,
and Petes, T. D.
(1998)
Mol. Cell. Biol.
18,
2779-2788 |
| 21. | Tishkoff, D. X., Filosi, N., Gaida, G. M., and Kolodner, R. D. (1997) Cell 88, 253-263[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Schweitzer, J. K.,
and Livingston, D. M.
(1998)
Hum. Mol. Genet.
7,
69-74 |
| 23. |
White, P. J.,
Borts, R. H.,
and Hirst, M. C.
(1999)
Mol. Cell. Biol.
19,
5675-5684 |
| 24. |
Henricksen, L. A.,
Tom, S.,
Liu, Y.,
and Bambara, R. A.
(2000)
J. Biol. Chem.
275,
16420-16427 |
| 25. |
Teraoka, H.,
Minami, H.,
Iijima, S.,
Tsukada, K.,
Koiwai, O.,
and Date, T.
(1993)
J. Biol. Chem.
268,
24156-24162 |
| 26. | Harrington, J. J., and Lieber, M. R. (1994) EMBO J. 13, 1235-1246[Medline] [Order article via Infotrieve] |
| 27. |
Murante, R. S.,
Rust, L.,
and Bambara, R. A.
(1995)
J. Biol. Chem.
270,
30377-30383 |
| 28. | Spiro, C., Pelletier, R., Rolfsmeier, M. L., Dixon, M. J., Lahue, R. S., Gupta, G., Park, M. S., Chen, X., Mariappan, S. V., and McMurray, C. T. (1999) Mol. Cell 4, 1079-1085[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Ireland, M. J.,
Reinke, S. S.,
and Livingston, D. M.
(2000)
Genetics
155,
1657-1665 |
| 30. |
Jin, Y. H.,
Obert, R.,
Burgers, P. M.,
Kunkel, T. A.,
Resnick, M. A.,
and Gordenin, D. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
5122-5127 |
| 31. | Saenger, W. (1984) in Principles of Nucleic Acid Structure (Cantor, C. R., ed) , Springer-Verlag Inc., New York |
| 32. |
Schweitzer, J. K.,
and Livingston, D. M.
(1999)
Genetics
152,
953-963 |
| 33. | Gacy, A. M., Goellner, G., Juranic, N., Macura, S., and McMurray, C. T. (1995) Cell 81, 533-540[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Jakupciak, J. P.,
and Wells, R. D.
(2000)
J. Biol. Chem.
275,
40003-40013 |
| 35. |
Jankowski, C.,
Nasar, F.,
and Nag, D. K.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2134-2139 |
| 36. | Richard, G. F., Goellner, G. M., McMurray, C. T., and Haber, J. E. (2000) EMBO J. 19, 2381-2390[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Kovtun, I. V., and McMurray, C. T. (2001) Nat. Genet. 27, 407-411[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Freudenreich, C. H.,
Kantrow, S. M.,
and Zakian, V. A.
(1998)
Science
279,
853-856 |
| 39. |
Budd, M. E.,
Choe, W.,
and Campbell, J. L.
(2000)
J. Biol. Chem.
275,
16518-16529 |
| 40. |
Bae, S. H.,
and Seo, Y. S.
(2000)
J. Biol. Chem.
275,
38022-38031 |
| 41. |
Rolfsmeier, M. L.,
Dixon, M. J.,
Pessoa-Brandao, L.,
Pelletier, R.,
Miret, J. J.,
and Lahue, R. S.
(2001)
Genetics
157,
1569-1579 |
| 42. | Pearson, C. E., and Sinden, R. R. (1998) Curr. Opin. Struct. Biol. 8, 321-330[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
D. L. Daee, T. Mertz, and R. S. Lahue Postreplication Repair Inhibits CAG {middle dot} CTG Repeat Expansions in Saccharomyces cerevisiae Mol. Cell. Biol., January 1, 2007; 27(1): 102 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Bartos, W. Wang, J. E. Pike, and R. A. Bambara Mechanisms by Which Bloom Protein Can Disrupt Recombination Intermediates of Okazaki Fragment Maturation J. Biol. Chem., October 27, 2006; 281(43): 32227 - 32239. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, L. A. Lindsey-Boltz, A. Sancar, and R. A. Bambara Mechanism of Stimulation of Human DNA Ligase I by the Rad9-Rad1-Hus1 Checkpoint Complex J. Biol. Chem., July 28, 2006; 281(30): 20865 - 20872. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Refsland and D. M. Livingston Interactions Among DNA Ligase I, the Flap Endonuclease and Proliferating Cell Nuclear Antigen in the Expansion and Contraction of CAG Repeat Tracts in Yeast Genetics, November 1, 2005; 171(3): 923 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Wells, R. Dere, M. L. Hebert, M. Napierala, and L. S. Son Advances in mechanisms of genetic instability related to hereditary neurological diseases Nucleic Acids Res., July 8, 2005; 33(12): 3785 - 3798. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang and R. A. Bambara Human Bloom Protein Stimulates Flap Endonuclease 1 Activity by Resolving DNA Secondary Structure J. Biol. Chem., February 18, 2005; 280(7): 5391 - 5399. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dere, M. Napierala, L. P. W. Ranum, and R. D. Wells Hairpin Structure-forming Propensity of the (CCTG{middle dot}CAGG) Tetranucleotide Repeats Contributes to the Genetic Instability Associated with Myotonic Dystrophy Type 2 J. Biol. Chem., October 1, 2004; 279(40): 41715 - 41726. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Ruggiero and M. D. Topal Triplet Repeat Expansion Generated by DNA Slippage Is Suppressed by Human Flap Endonuclease 1 J. Biol. Chem., May 28, 2004; 279(22): 23088 - 23097. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, H. Zhang, J. Veeraraghavan, R. A. Bambara, and C. H. Freudenreich Saccharomyces cerevisiae Flap Endonuclease 1 Uses Flap Equilibration To Maintain Triplet Repeat Stability Mol. Cell. Biol., May 1, 2004; 24(9): 4049 - 4064. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Ma, E. M. Kim, J. E. Haber, and S. E. Lee Yeast Mre11 and Rad1 Proteins Define a Ku-Independent Mechanism To Repair Double-Strand Breaks Lacking Overlapping End Sequences Mol. Cell. Biol., December 1, 2003; 23(23): 8820 - 8828. [Abstract] [Full Text] [PDF] |
||||
![]() |